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Background. Growth failure is a common feature of children with human immunodeficiency virus (HIV) infection. Malnutrition
increases mortality and may impair the response to antiretroviral treatment. Objective. Our objective was to describe the prevalence
of stunting, underweight, and wasting in HIV-infected children in south India and to assess the utility of these parameters
in predicting immune status. Methodology. In this cross-sectional study, anthropometric measurements and CD4 counts were
performed on 231 HIV-infected children. Z scores for height for age, weight for age, and weight for height were correlated with
CD4 cell counts and receiver operating characteristic curves plotted. Results. Prevalence of underweight was 63%, stunting 58%,
and wasting 16%, respectively. 33–45% of children were moderately or severely malnourished even at CD4 >25%; sensitivity
and specificity of stunting or underweight to predict HIV disease severity was low. Conclusions. Undernutrition and stunting are
common among HIV-infected children at all stages of the disease in India. Early and aggressive nutritional intervention is required,
if long-term outcomes are to be improved.
Copyright © 2009 C. Padmapriyadarsini et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Introduction
The UNAIDS report on the global AIDS epidemic estimated
that approximately 420 000 (350 000–540 000) new HIV
infections occurred in children below 15 years of age in
the year 2007, 90% of them through mother to child
transmission [1]. Malnutrition has been shown to be an
important comorbid condition, as the same populations that
are vulnerable to HIV also have a high prevalence of food
insecurity [2]. There is limited data on the prevalence and
type of malnutrition (underweight, stunting, and wasting)
among HIV-infected children in India [3], though it is
known that protein energy malnutrition is one of the com-
monest manifestations of HIV in this region [4, 5]. While
malnutrition itself is multifactorial in causation, the most
eﬀective treatment for this failure to grow in HIV-infected
children appears to be antiretroviral therapy [6]. Further, the
use of growth monitoring in health care settings caring for
HIV-infected children could lead to an earlier identification
of malnutrition and appropriate interventions, including
nutritional counseling, supplementation, and ART [7].
The Tuberculosis Research Centre has been following
a cohort of HIV-infected children from 2001 in Chennai
and Madurai cities of Tamil Nadu, south India. Data from
this study of HIV-infected children provided us with a
unique opportunity to describe the prevalence of stunting,
underweight, and wasting at presentation and also examine
any relationship with age, sex, and stage of the disease. We
investigated whether any of these indices of nutritional status
could predict the immune status of the child or serve as
surrogate markers of disease severity. If so, they could be
potentially used in peripheral health care settings, where
facilities for sophisticated laboratory monitoring may not be
available.
2. Materials and Methods
This was a cross-sectional study of children infected with
HIV, between the ages of 0 and 15 years, who were referred
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Table 1: Demographic profile of the study population.
Variable Overall (n = 231) (mean±SD) Girls (n = 134) (mean±SD) Boys (n = 97) (mean±SD)
Age (months) 71± 40 72± 39 69± 41.0
Weight (kgs) 14.4± 5.9 14.5± 5.7 14.4± 6.2
Height (cms) 99.7± 20.7 100.5± 18.8 98.7± 22.9
Body mass index (kg/m2) 14.2± 1.8 14.2± 1.8 14.2± 1.7
CD4 (%) 17.7± 10.2 18.5± 11.1 16.5± 8.6
CD4 Count (cells/mm3) 793± 614 785± 636 805± 583
Hemoglobin (gms/dl) 9.7± 2.1 9.8± 2.1 9.6± 2.0
to the outpatient clinics of Tuberculosis research Centre
(TRC) in the cities of Chennai and Madurai, south India
between May 2001 and December 2007. Children already
on antiretroviral therapy (ART), in a moribund state, not
willing for regular hospital visits or blood draw as per
the study protocol were excluded. Children were assessed
clinically, examined for physical and mental development,
nutritional status, and any evidence of opportunistic infec-
tions including tuberculosis. Staging was done using the
WHO clinical staging chart [8] and CD4 count and CD4
percentage measured by standard flow cytometric methods
using the Beckman Coulter Epics XL.
Children were referred for ART initiation if eligible, as
per WHO and national guidelines [8]. However, provision of
free ART was launched by the government of India in April
2004 and a special pediatric initiative in November 2006.
Prior to this, access to ART was limited as very few patients
could aﬀord to buy these drugs. The study was approved
by the Institutional Ethics committee of TRC and written
informed consent was obtained from the parent or legal
guardian.
Children were included in this analysis if measurements
for height and weight were obtained upon enrollment. The
Z-scores for weight, height and BMI were computed based
on the child’s age and gender using the EPI-NUT component
of the EPI-INFO 2002 software package (version 3.4.3)
from CDC (based on NCHS reference median values). The
WHO Global Database on Child Growth and Malnutrition
recommends a cutoﬀ z score of < −2 to classify low
weight-for-age (underweight), low height-for-age (stunting),
and low weight-for-height (wasting) as moderate and a z
score of < −3 standard deviations (SD) to define severe
undernutrition [6]. A z score of < −2 indicates that a child’s
height for age (HAZ), weight for age (WAZ), or weight for
height (WHZ) is 2 SD below the age and gender-specific
median for the normal population.
2.1. Data Analysis. SPSS version 11.0 was used for statistical
analysis. The prevalence of underweight, stunting, and
wasting were calculated for the diﬀerent age groups and both
sexes and the severity classified based on z scores. Diﬀerences
in the proportions of wasting, stunting, and underweight
among boys and girls and at various ages were tested with
the chi-square test. Correlation between CD4% and growth
indices was obtained using Pearson’s correlation coeﬃcient.
Receiver Operating Characteristic curves were constructed to
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Figure 1: Proportion of children with underweight (WAZ < −2 SD)
and stunting (HAZ < −2 SD) in diﬀerent age groups. ∗P < .05
versus 3–5 and 5–10 years age group.
assess the relationship between HAZ and WAZ with CD4%
and to determine the cutoﬀ which would predict immune
deficiency with optimal sensitivity and specificity.
3. Results
A total of two hundred and thirty one antiretroviral-naı¨ve
HIV-infected children were enrolled during the period under
study. The average age of the children at presentation was
approximately 71 months with 17% under 3 years of age.
42% were boys and majority of the children were in WHO
clinical stage 3. The mean CD4 percentage was 17.7 ± 10
(SD)% and the average BMI was 14.2± 2 (Table 1).
In this cohort, the prevalence of underweight (WAZ
< −2) was 63%, stunting (HAZ < −2) 58%, and wasting
(WHZ < −2) 16%, respectively, (Table 2). While a higher
proportion of boys were underweight compared to girls, the
rates of stunting and wasting were similar. Figure 1 shows
the proportion of underweight and stunted children in the
various age categories. Children below 3 years of age and
above 10 years of age were at a significantly higher risk of
severe underweight when compared with children between
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Table 2: Gender wise prevalence of malnutrition among HIV-infected Children.
Anthropometric indices Total number of Children N (%) Girls N (%) Boys N (%) p value
Study population 231 134 97
Underweight (WAZ < −2) 146 (63) 77 (58) 69 (71) 0.03
Stunting (HAZ < −2) 134 (58) 72 (54) 62 (64) 0.14
Wasting (WHZ < −2) 38 (16) 19 (14) 19 (20) 0.37
Table 3: Mean CD4% and CD4 cell count of children in diﬀerent age groups as well as in those with underweight and stunting.
<3 years 3–5 years 5–10 years >10 years
All children
CD4% 17.3± 6.6 19.2± 13.2 17.6± 9.4 15.8± 10.8
CD4 count (cells/mm3) 1120± 619 1036± 778 666± 472 423± 345
Underweight
CD4% 16.9± 7.0 15.8± 7.9 14.6± 8.6 11.4± 7.8
CD4 count (cells/mm3) 1117± 638 842± 591 581± 483 305± 276
Stunted
CD4% 17.0± 6.9 16.2± 8.2 15.5± 9.2 14.0± 10.1
CD4 count (cells/mm3) 1180± 643 888± 577 644± 537 337± 277
the ages 3–10 years but the proportion of stunted children
was similar across all age groups. Severe stunting was found
in >40% of children at all age groups. The proportion of
children with normal nutritional status (WAZ and HAZ >
−1) tended to decrease with increasing age. Table 3 shows
the mean CD4% and CD4 cell count of all children as well
as in the subsets with either underweight or stunting, with a
clear trend towards lower cell count and percentage among
children above the age of 10 years in all three groups.
We examined the relationship between CD4 percentage
and the various growth parameters. CD4% was available for
194 children with 41% of them showing severe immunode-
ficiency (CD4 < 15%) at the time of initial presentation. Of
these children with CD4 < 15%, 71% were stunted (HAZ
< −2) and 76% were underweight (WAZ < −2). Table 4
shows the prevalence of diﬀerent types of malnutrition in
children at diﬀerent levels of immunodeficiency. Higher
rates of moderate to severe stunting and underweight were
observed among children with CD4 < 15% (P < .001)
compared to those at higher CD4 counts. There was a
moderate correlation between WAZ and CD4% (r = 0.3,
P < .005) and between HAZ and CD4% (r = 0.28, P < .005).
Even at CD4 counts >25% indicating normal immune status,
33 to 45% of children had moderate to severe malnutrition.
The sensitivity and specificity of stunting (HAZ < −2) to
predict CD4 < 15% was 63% and 67% while undernutrition
(WAZ < −2) could predict a CD4 < 15% with a sensitivity
of 60% and specificity of 61%, respectively. Further, the area
under the ROC Curve for WAZ and CD4% was 0.66 (95% CI
0.58–0.74) while for HAZ and CD4% area under the curve
was 0.69 (95% CI 0.62–0.77), Figures 2(a) and 2(b).
Table 4: Prevalence of underweight, stunting, and wasting at
diﬀerent levels of immunodeficiency.
Malnutrition scores
Levels of immunodeficiency
CD4 < 15% CD4 15–25% CD4 > 25%
N = 79 N = 82 N = 33
n (%) n (%) n (%)
WAZ < −2 60 (76)∗ 50 (61) 11 (33)
HAZ < −2 56 (71)∗ 44 (54) 14 (42)
WHZ < −2 12 (15) 15 (18) 3 (9)
∗P < .001 across levels of immunodeficiency.
4. Discussion
The overall prevalence of moderate to severe underweight
and stunting in this population of HIV-infected children
from South India was 63% and 58%, which is cause for
concern. In children under 5 years, the prevalence was 66%
and 62%, respectively—this is much higher than the national
average of 48% underweight and 40% stunting reported by
NFHS-3 for under-five children [9]. Our findings are similar
to rates of undernutrition among HIV-infected children
reported from other parts of India, which vary from 60 to
62% [4, 10]. These figures are higher than those reported
among HIV infected children in Africa, which varies between
14% for undernutrition and 31% for stunting to 38% for
malnutrition, [11–13]. Our data highlights the much higher
rate of moderate and severe grades of malnutrition among
HIV-infected children in India. The children included in this
report were seeking care at government health facilities and
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Figure 2: (a) Receiver Operator Characteristic curve between WAZ score and CD4 percentage, and (b) HAZ score and CD4 percentage.
represent the majority of HIV-infected people in India, who
are from the socioeconomically vulnerable group.
This is important as malnutrition has a major impact
on the outcome of HIV disease as it not only increases
mortality [12, 13] but also results in an impaired response
to antiretroviral therapy [14]. Rajasekaran et al. showed
that children who were severely malnourished at baseline,
had a hazard ratio of 6.7 (0.9–49.4) for mortality after
initiation of ART, compared to children who were normally
nourished [14]. However nutritional recovery and growth
after treatment of malnutrition is similar to that observed
in HIV uninfected children, stressing the need for early
recognition and management [15]. We explored this area
in depth as none of the previous studies from India have
examined the pattern and type of malnutrition in detail
or attempted to study its correlation with age, gender, or
immune status.
In our study, the prevalence of moderate to severe
undernutrition was significantly diﬀerent among the various
age groups with higher rates of underweight among children
less than 3 years of age and above 10 years of age. The
increased risk of malnutrition in younger children may be
due to a combination of factors like weaning from the
breast, inadequate supplementary feeding, lose of passive
immunity received from mother, and so forth, all leading
to recurrent infections and a poorly nourished child. After
the age of 10 years we see another rise in the rate of
severe malnutrition and this could be explained by the fact
that by this age many children start showing evidence of
disease progression. In our study we observed that children
above 10 years of age had lower mean CD4% and CD4 cell
counts, indicating more advanced disease. The CD4 counts
were lower in children with stunting and undernutrition
compared to the age group as a whole—CD4% which are
more stable than absolute counts also showed a decline. The
proportion of children with “normal” nutrition decreased
with advancing age. Wasting was relatively less prevalent in
our cohort suggesting that malnutrition was of chronic onset
and not an acute entity, unlike a report from Malawi where
the commonest physical sign was wasting in more than 70%
of the infected children [16].
While immune status and malnutrition showed a fair
correlation, the presence of moderate stunting or under-
nutrition could not be used to predict disease severity
very accurately. Among children with moderate to severe
stunting, though the majority had low CD4%, almost one
fourth of children in this group had CD4 > 15%. Similarly,
while underweight (WAZ < −2) children commonly had
CD4 < 15%, a quarter of these children also had a CD4% >
15%. The sensitivity and specificity of predicting CD4%
using either HAZ or WAZ was not very satisfactory. The
area under the ROC curve for both WAZ and HAZ was in
the range of 0.6–0.7, indicating poor diagnostic accuracy.
Because malnutrition is common at all stages of HIV disease,
stunting or undernutrition cannot be used as a surrogate
marker for predicting disease stage or severity. Our study also
highlights the fact that even at relatively early stages of the
disease with higher CD4 counts, malnutrition is a substantial
problem with over a third of children moderately or severely
malnourished. By the time they reach a stage of advanced
immunodeficiency, approximately three-quarters are stunted
and underweight. Hence, there is a need for nutritional
intervention at an early stage of the disease, as stunting may
not be completely reversible if it is long standing.
The strengths of our study are that this was a group
of well-characterized HIV-infected children representing all
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age groups. Both anthropometric and CD4 measurements
were performed using standardized methods. There are a
few limitations to our study. Since this study was cross-
sectional in design, it was diﬃcult to examine any temporal
relationships between malnutrition and disease outcomes. As
very sick children were not enrolled into this pediatric cohort
study, there is the possibility of selection bias, thus under-
estimating the actual prevalence of growth abnormalities.
On the other hand, these children all came to a tertiary
level centre to seek care and may therefore represent the
more severely aﬀected end of the spectrum. Further, the
average age of this cohort was 6 years which is typical of
HIV-infected children presenting to care in India. We have
previously reported on infants with perinatally acquired HIV
infection (virologically confirmed) who show rapid disease
progression and die even before two years of age, mostly
undiagnosed and uninitiated on treatment. Thus, we may
have missed the most severely aﬀected infants who never
present to care till they are severely ill or moribund [17].
The findings from our study may not necessarily be reflective
of the situation in other developing countries of Asia and
Africa, where patterns of malnutrition vary. However, we
have drawn attention to this important area which needs
further research.
In summary, we have found that malnutrition (both
stunting and underweight) is highly prevalent among HIV-
infected children in India, at all ages and at all stages of
HIV disease. Growth failure cannot be used as a surrogate
marker to stage HIV disease as it occurs even at relatively
higher CD4 levels. Malnutrition should be targeted early to
ensure optimal response to ART and reduce early mortality.
Future studies should also examine the impact of nutritional
supplementation started at diﬀerent stages of HIV disease on
reducing HIV-related mortality and morbidity in children
and in modifying long-term treatment outcomes.
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